Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simulated Driving Performance in XP13512 Treated RLS Patients
NCT01332318Phase 2Completed
- Sponsor
- XenoPort, Inc.
- Start
- Apr 2007
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gabapentin enacarbil in restless legs syndrome (RLS), sponsored by XenoPort, Inc.. Started Apr 2007; status: completed.
02
Drugs
gabapentin enacarbil
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT01332318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01332318.